Jump to content

Indium (111In) imciromab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 15:45, 27 March 2020 (added FDA UNII to drug box). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Indium (111In) imciromab
Monoclonal antibody
TypeFab fragment
SourceMouse
Targetcardiac myosin
Clinical data
Trade namesMyoscint
ATC code
Legal status
Legal status
  • withdrawn
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒NcheckY (what is this?)  (verify)

Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111.[1] It was used for cardiac imaging, but withdrawn in 1993.[2]

See also

References

  1. ^ WHO Drug Information
  2. ^ DiagnosticImaging.com: Centocor withdraws imaging agent applications


Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Indium_(111In)_imciromab&oldid=947640413"